Christopher A Hamm

Title: Christopher A Hamm: Innovator in Immune Response Scoring

Introduction

Christopher A Hamm is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of immunology through his innovative patent. His work focuses on methods for determining an immune response score, which is crucial for understanding anti-tumor immune cell signaling and activation.

Latest Patents

Christopher A Hamm holds a patent titled "Methods of determining an immune response score." This patent outlines a method for determining an immune response score (irScore) by assessing differentially expressed genes involved in anti-tumor immune cell signaling and immunosuppression. The irScore is calculated based on the number of genes implicated in these processes, providing a valuable tool for evaluating immune responses in clinical settings. He has 1 patent to his name.

Career Highlights

Christopher A Hamm is associated with American Molecular Laboratories Inc., where he applies his expertise in immunology and molecular biology. His work at the company emphasizes the importance of understanding immune responses in the context of cancer treatment and research.

Collaborations

One of his notable coworkers is Sarah S Bacus, with whom he collaborates on various projects related to immune response and molecular diagnostics.

Conclusion

Christopher A Hamm's innovative work in determining immune response scores represents a significant advancement in immunology. His contributions are essential for enhancing our understanding of immune responses in cancer therapy.